Literature DB >> 25695239

Tubular dysfunction and non-albuminuric renal disease in subjects with type 2 diabetes mellitus.

Ma Ludivina Robles-Osorio, Ernesto Sabath1.   

Abstract

INTRODUCTION: Micro-albuminuria is considered an early marker of glomerular injury in patients with diabetes but it has yet to be determined whether testing for markers of tubular injury can also identify people who are at risk of progressive renal disease.
OBJECTIVE: To evaluate markers of tubular injury and renal characteristics in a sample of community treated type 2 diabetic subjects.
MATERIAL AND METHODS: We carry-out an assessment of a group of community diabetic patients, anthropometric measures, creatinine clearance, HbA1c, lipid profile, the mean fast serum glucose levels, albuminuria and α1-microglobulin (α1M) urine excretion were evaluated.
RESULTS: From 95 included patients, 45.2% had α1M urinary excretion ≥ 10 μg/gCr, 23.1% micro-albuminuria, 9.6% macroalbuminuria and 27.2% had a GFR < 60 mL/min. The most important risk factor associated with a1M excretion was fasting glucose level (OR 4.3, 95IC 1.7-11.1 p = 0.001); HbA1c ≥ 8% and age were the most important risk factors associated with GFR ≤ 60 mL/min. Most of patients had uncontrolled glucose levels and 45.1% patients with albuminuria were not receiving any drug with anti-proteinuric effects.
CONCLUSIONS: Fasting glucose levels was the most important risk factor associated with tubular dysfunction; non-albuminuric presentation of CKD defined as GFR < 60 mL/min was frequent in our population, so is necessary to implement different strategies for surveillance in patients with type 2 diabetes aiming to delay progression to CKD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25695239

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  6 in total

Review 1.  Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.

Authors:  Zubair Ilyas; Joumana T Chaiban; Armand Krikorian
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

2.  A GC-MS-Based Metabolomics Investigation of the Protective Effect of Liu-Wei-Di-Huang-Wan in Type 2 Diabetes Mellitus Mice.

Authors:  Jian-Hua Huang; Dan He; Lin Chen; Qing Du; Rong Yu; Ping Cai; Shui-Han Zhang
Journal:  Int J Anal Chem       Date:  2020-08-13       Impact factor: 1.885

Review 3.  The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.

Authors:  Tomás P Griffin; William Patrick Martin; Nahidul Islam; Timothy O'Brien; Matthew D Griffin
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

4.  Association of neutrophil-gelatinase-associated lipocalin with microvascular complications in patients with type 2 diabetes: a cross-sectional study.

Authors:  Erhan Aslanhan; David Ojalvo; Ekmek Burak Özsenel; Sema Ucak Basat; Fatih Borlu
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-09-10

5.  Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients.

Authors:  Temesgen Fiseha
Journal:  Biomark Res       Date:  2015-07-04

Review 6.  Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.

Authors:  Temesgen Fiseha; Zemenu Tamir
Journal:  Int J Nephrol       Date:  2016-05-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.